济南前列腺钙化能治疗好么济南阴茎敏感神经过多怎么办,济南男科主要看什么病的,济南阳萎早泄能治疗吗,济南男人滑精早泄怎么办,济南治疗早泄啥药好,济南割包皮哪好,济南前列腺炎多久会好

The White House Correspondents' Association is shelving its tradition of having a comedian roast the president and the press corps at its annual fundraising dinner.Instead, the famed author Ron Chernow will "share his lively, deeply researched perspectives on American politics and history at the 2019 White House Correspondents' Dinner," the association's president Olivier Knox said.Knox made the announcement on Monday. For several months, he had been leaning against inviting a comic, and he had been conferring with other members about the change.President Trump has snubbed the event two years in a row, and there is little reason to believe that he will attend next dinner, which is scheduled for April 27, 2019.The dinner is a key date on Washington's social calendar. But its meaning has changed amid constant attacks on the media and increasing political polarization. Booking Chernow instead of a stand-up performer is a recognition that the annual dinner changes dramatically when the president isn't there.So the association had to rethink things.Historically, Knox told CNN earlier this year, "when the president comes, the program's center of gravity naturally tilts toward the president." After he speaks and ribs the press corps, the featured comedian serves as the counter-balance. But with the president absent, the dinner has a different, more combative feel.Knox and the association's board members are trying to change that."As we celebrate the importance of a free and independent news media to the health of the republic, I look forward to hearing Ron place this unusual moment in the context of American history," Knox said in a statement on Monday.Chernow is the author of six books, including best selling titles about Alexander Hamilton and George Washington. The Hamilton biography inspired Lin-Manuel Miranda's Broadway hit musical "Hamilton," and Chernow served as a historical consultant on the production.Chernow said in a statement, "The White House Correspondents' Association has asked me to make the case for the First Amendment and I am happy to oblige. Freedom of the press is always a timely subject and this seems like the perfect moment to go back to basics. My major worry these days is that we Americans will forget who we are as a people and historians should serve as our chief custodians in preserving that rich storehouse of memory. While I have never been mistaken for a stand-up comedian, I promise that my history lesson won't be dry."Comedienne Michelle Wolf spurred debate about the dinner format when she performed at last April's dinner.Some attendees loved her set, while others cringed at some parts of it.Afterward, Trump allies claimed that the jokes proved the press corps' hatred of Trump. Trump tweeted that the dinner was "embarrassing" and the event is "dead."The correspondents' association -- which did not vet her monologue ahead of time -- expressed regret that the controversy over the jokes overshadowed the dinner's First Amendment message. 3019

The U.S. reported yet another daily high mark for newly reported cases of COVID-19 on Thursday with nearly 188,000, according to a database kept by Johns Hopkins University.The U.S. reported at least 187,833 positive COVID-19 tests on Thursday, breaking the all-time record of 177,224 that was set six days prior, on Nov. 13.Thursday marked the eighth time in November that the U.S. broke the daily record for newly reported cases as the COVID-19 continues to spread across the country. About 2.5 million people in the U.S. have contracted the virus since the start of November.The spike in cases has led to all-time highs in hospitalizations linked to the virus. The COVID Tracking Project reports that more than 80,000 people are currently hospitalized with the virus across the country — an all-time record that surpasses even the early portions of the pandemic. According to the COVID Tracking Project, 71% of those hospitalizations occur in the Midwest and South, leading to many rural hospitals running short on resources. Some states like South Dakota and Iowa say their hospitals are at their breaking points.Thursday also saw reports of 2,000 deaths linked to the virus — the first time the U.S. has seen that many reported deaths in a single day since May 6. Since Oct. 17, daily deaths linked to COVID-19 on a seven-day rolling average have nearly doubled from about 700 a day to more than 1,300 a day. The continued spike comes amid a rash of promising news in the hope for a COVID-19 vaccine. On Friday, Pfizer announced that it had filed for Emergency Use Authorization for its vaccine candidate, two days after initial studies showed it to be 95% effective in large-scale trials. Several other drugmakers have also reported that their vaccines are on the precipice of authorization.However, health experts warn that the U.S. is in for a rough few months. Vaccines will initially need to be rationed for people in high-risk populations and health care workers. Dr. Anthony Fauci has said he believes vaccines won't be widely available until April. 2075

The Trump administration plans to raise pending tariffs on 0 billion in Chinese goods to 25% from 10%, a source familiar with discussions confirmed to CNN.The news was first reported by Bloomberg.The move, which is not finalized and could change, according to the source, comes as the United States and China remain locked in a trade war. Talks between US and Chinese officials have done little to ease tensions.The United States has already imposed 25% tariffs on Chinese goods worth billion. China immediately responded with its own tariffs on US goods worth billion.A second round of tariffs on products worth billion could take effect as soon as this week.US Trade Representative Robert Lighthizer earlier this month ratcheted up tensions when he released a list of thousands of additional Chinese exports worth 0 billion that could face 10% tariffs after a public comment period. It included fruit and vegetables, handbags, refrigerators, rain jackets and baseball gloves.Those tariffs, which might now be steeper, could go into effect as soon as September. 1108

The US Food and Drug Administration expanded?the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.New to the list are some valsartan products manufactured by Hetero Labs Ltd. in India, which are labeled as Camber Pharmaceuticals Inc. Test results show that some of the products may be tainted.The FDA announced a valsartan recall in July after lab tests revealed that some drugs could have been tainted with a substance linked to higher risk of cancer. The drug had been recalled in 22 other countries. The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide. Not all of the drugs containing valsartan were affected.N-nitrosodimethylamine or NDMA, the impurity the lab tests found, is considered a?possible carcinogen by the US Environmental Protection Agency. It is an organic chemical that has been used to make liquid rocket fuel, and it can be unintentionally introduced through certain chemical reactions. It's a byproduct of the manufacturing of some pesticides and fish processing.The medicines that are now a part of this expanded list?in the recall are tablets sold by AvKare, A-S Medication Solutions LLC, Bryant Ranch Prepack Inc, Camber Pharmaceuticals, Inc. H J Harkins Company, Northwind Pharmaceuticals, NuCare Pharmaceuticals Inc., Prinston Pharmaceutical Inc. (labeled as Solco Healthcare LLC), Proficient Rx LP, Remedy Repack, Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis).The FDA also published a list of valsartan products that are not currently recalled. Only the drugs suspected of being tainted with NDMA are on the recall list. If you are taking a valsartan drug, look for the company name on your prescription bottle. If the information isn't on the label, you can call your pharmacy for those details.The recalled medicine is linked to a manufacturer in China. The substances were supplied by Zhejiang Huahai Pharmaceuticals, based in Linhai, in eastern China, which said it notified authorities as soon as it identified the impurity."We published our recall notice at midday on July 13 in China and overseas, and published the US market recall notice on July 14 Beijing time ... all the drug materials for the Chinese market were recalled by July 23," the company said in a statement to the Shanghai stock exchange last month.The FDA said on its website that it's working with drug manufacturers "to ensure future valsartan active pharmaceutical ingredients are not at risk."If you are worried that your drug could be on the recall list, talk with your doctor or pharmacist before changing any routine with your medicine. Because not all valsartan drugs are involved in the recall, they might be able to switch you to a version of the drug made by another company.If you know your drug is on the recall list, the FDA suggests you continue taking it until your doctor or pharmacist provides a replacement.To get a sense of what taking a tainted drug could mean, FDA scientists estimated that if 8,000 people took the highest dose of valsartan (320 milligrams) from the recalled batches every day for four years, there may be one additional case of cancer."The key with this is, patients should not stop taking their medication abruptly, that definitely can be harmful," Dr. Mary Ann Bauman, a representative for the American Heart Association, said in July. "You don't want to jump to any conclusions on your own about this medication, or any medication for that matter. Definitely talk with your doctor first." 3690

The US called on Turkey to not follow through on threats to attack US-backed forces in Syria Wednesday, an incursion the Pentagon warned could threaten US personnel and derail the fight against ISIS."Unilateral military action into northeast Syria by any party, particularly as US personnel may be present or in the vicinity, is of grave concern. We would find any such actions unacceptable," Commander Sean Robertson, a spokesman for the Department of Defense, told CNN."We believe this dialogue is the only way to secure the border area in a sustainable manner, and believe that uncoordinated military operations will undermine that shared interest," he added.Earlier on Wednesday, Turkey's President Recep Tayyip Erdogan said in a televised speech that Turkish troops would launch a military operation east of the Euphrates in Syria, an operation aimed at targeting Kurdish militants.The US troops in Syria regularly work with Kurdish elements of the Syrian Democratic Forces as part of their campaign against ISIS.Turkey sees all Kurdish forces in in Northern Syria as an extension of the Kurdistan Workers' Party (PKK), listed as terror group by the US and the EU. The US does not share Turkey's view."Our target is definitely not American troops. It is the members of terror organization operating in the region. I want to emphasize this," Erdogan added, saying that he expected the operation to begin "in a couple of days."Secretary of Defense James Mattis recently directed US troops to establish a series of observation posts in the northeast Syria border region as part of an effort to reduce tensions between Turkey and the US-backed Syrian Democratic Forces.Two US officials told CNN that while the US has observed additional Turkish forces arriving in the area, at this point in time it is assessed that Turkey does not have enough troops in the area to conduct the type of operation in the timeline outlined by Erdogan.However the threat of cross-border shelling remains, potentially putting US troops there at risk.Previous cross-border clashes caused the Syrian Democratic Forces to suspend their hard-fought offensive against the ISIS-held town of Hajin, the terror group's last remaining redoubt east of the Euphrates River."The campaign against ISIS is not over. Coalition forces are working closely with the Syrian Democratic Forces who are in the midst of offensive operations against ISIS in the Middle Euphrates River Valley," Robertson, the Pentagon spokesman said."We should not and cannot allow ISIS to breathe at this critical point or we will jeopardize the significant gains we have made alongside our Coalition partners and risk allowing ISIS to resurge," he added. 2703